Arca
Skip to content

JAK3: Tyrosine-protein kinase JAK3

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation.

  • Drugs that act on it: 11
  • With a US drug page: 2
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
RitlecitinibApprovedTyrosine-protein kinase JAK3 inhibitorInhibitorBoxed warning
UpadacitinibApprovedTyrosine-protein kinase JAK3 inhibitorInhibitorBoxed warning
AT-9283—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
Cerdulatinib—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
Decernotinib—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
Filgotinib—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
R-333—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
R-348—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
Ruxolitinib—Tyrosine-protein kinase JAK3 inhibitorInhibitorBoxed warning
Tricetamide—Tyrosine-protein kinase JAK3 inhibitorInhibitor—
WHI-P131—Tyrosine-protein kinase JAK3 inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
T-B+ severe combined immunodeficiency due to JAK3 deficiency
0.84
Atopic eczema
0.59
Crohn disease
0.56
Acquired polycythemia vera
0.55
Graft versus host disease
0.54

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
JAK3

Drugs and mechanisms are from ChEMBL CHEMBL2148 (CC BY-SA 3.0). Gene name, function (UniProt P52333, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.